Dexcom (DXCM)

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
ESG term mentions
In last year of SEC filings
AirCircularCleanClimateClimate ChangeContaminantCoralEcosystemEnvironmentEnvironmentalExtreme WeatherForestIntensityLeachLife CycleLifecycleMaterialsNatural ResourcesNatureOffsetPackagePackagingPandemicPlasticRaw MaterialsWasteWaterAccessAffordabilityAfrican AmericanAsianAttritionBenefitsBlackCalifornia Consumer Privacy ActCitizenshipCollective BargainingCommunityCultureCustomerCustomer SatisfactionCyberCybersecurityData PrivacyData SecurityDeathDemographicDemographicsDisabilityDiversityEmployeeEmployee EngagementEmployee Resource GroupEmployee RetentionEngagementEthnicEthnicityFrontline WorkersGenderGeneral Data Protection RegulationHealth and SafetyHealth CareHealthcareHireHiringHispanicHuman CapitalHuman ResourcesIncidentInjuryLatinxLGBTQMinorityPay EquityPay for PerformancePay ParityPerquisitesPrivacyProduct QualityRecallRecruitReimbursementRetentionRetirementSafetySatisfactionSkilledSkillsSocialStakeholderSupplierSupply ChainSupply Chain ManagementTalentTrainingUnionVolunteerWomenWorkersWorkforceWorkplace SafetyAnti-corruptionAssessmentAssuranceAttorneys GeneralAuditBoard EvaluationBonusBriberyChronicClassifiedClawbackCommitmentConflict of InterestCorporate GovernanceCorporate PurposeCorporate Social ResponsibilityCorruptionDepartment ofEnterprise Risk ManagementESGEthicsExecutive CompensationExpertFraudGoalsGovernanceHedgingIncentiveIncentivizeIndependenceIndependentInnovateInnovationInnovativeInvestigationLawsuitLead Independent DirectorLeadershipLitigationLong-termMajorityMaterialityMissionOverseeOversightPerquisitePledgingProcurementProxy AccessProxy ContestPurposeQuality StandardR&DReputationReputationalResearch and DevelopmentResponsibilityResponsibleSelf-evaluationSpecial MeetingStrategySustainabilitySustainableTargetsTaxTenureTransparencyVoting Rights
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
(a) Proxies for DexCom’s Annual Meeting of Stockholders (the “Annual Meeting”) were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on the record date, there were 96,705,867 shares outstanding and entitled to vote and 86,703,748 shares were voted online, via telephone or by proxy on the matters described below.
(b) The matters described below were voted on at the Annual Meeting and the number of votes cast with respect to each matter was as indicated:
(1) Holders of DexCom’s common stock voted to elect three Class I directors, each to serve until the DexCom’s 2024 Annual Meeting of Stockholders and until their successor has been elected and qualified, or until their earlier death, resignation or removal as follows:

Kevin R. Sayer78,775,2662,986,211345,9534,596,317
Nicholas Augustinos68,863,67113,203,63740,1234,596,317
Bridgette P. Heller81,245,908822,66938,8544,596,317
(2) Holders of DexCom’s common stock voted to ratify the selection by the Audit Committee of the Board of Directors for the appointment of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2021:

Number of Shares
Shares Voted in Favor:83,456,097
Shares Voted Against:3,211,326
Shares Abstaining:36,325

(3) Holders of DexCom’s common stock voted to approve the non-binding vote on an advisory resolution on compensation paid to DexCom’s named executive officers, as disclosed pursuant to